HK1189571A1 - Process and intermediates for synthesizing agomelatine - Google Patents

Process and intermediates for synthesizing agomelatine

Info

Publication number
HK1189571A1
HK1189571A1 HK14102651.0A HK14102651A HK1189571A1 HK 1189571 A1 HK1189571 A1 HK 1189571A1 HK 14102651 A HK14102651 A HK 14102651A HK 1189571 A1 HK1189571 A1 HK 1189571A1
Authority
HK
Hong Kong
Prior art keywords
intermediates
synthesizing agomelatine
agomelatine
synthesizing
Prior art date
Application number
HK14102651.0A
Other languages
English (en)
Chinese (zh)
Inventor
Samir Zard
Batrice Sire
Mehdi Boumediene
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44088993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1189571(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1189571A1 publication Critical patent/HK1189571A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK14102651.0A 2011-01-05 2014-03-17 Process and intermediates for synthesizing agomelatine HK1189571A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1100024A FR2970000B1 (fr) 2011-01-05 2011-01-05 Nouveau procede de synthese de l'agomelatine
PCT/FR2012/000005 WO2012113999A1 (fr) 2011-01-05 2012-01-04 Procede et intermediaires de synthese de l ' agomelatine

Publications (1)

Publication Number Publication Date
HK1189571A1 true HK1189571A1 (en) 2014-06-13

Family

ID=44088993

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14102651.0A HK1189571A1 (en) 2011-01-05 2014-03-17 Process and intermediates for synthesizing agomelatine

Country Status (43)

Country Link
US (2) USRE46218E1 (xx)
EP (1) EP2661422B9 (xx)
JP (1) JP5837616B2 (xx)
KR (1) KR101543432B1 (xx)
CN (1) CN103313965B (xx)
AP (1) AP3609A (xx)
AR (1) AR084780A1 (xx)
AU (1) AU2012220474B2 (xx)
BR (1) BR112013017307A2 (xx)
CA (1) CA2823587C (xx)
CL (1) CL2013001882A1 (xx)
CO (1) CO6731101A2 (xx)
CR (1) CR20130301A (xx)
CU (1) CU24289B1 (xx)
CY (1) CY1117774T1 (xx)
DK (1) DK2661422T3 (xx)
EA (1) EA022077B1 (xx)
EC (1) ECSP13012735A (xx)
ES (1) ES2583682T3 (xx)
FR (1) FR2970000B1 (xx)
GE (1) GEP20156365B (xx)
HK (1) HK1189571A1 (xx)
HR (1) HRP20160713T1 (xx)
HU (1) HUE028471T2 (xx)
IL (1) IL227281A (xx)
JO (1) JO3200B1 (xx)
ME (1) ME02408B (xx)
MX (1) MX2013007837A (xx)
MY (1) MY162977A (xx)
NI (1) NI201300062A (xx)
PE (1) PE20140037A1 (xx)
PL (1) PL2661422T3 (xx)
RS (1) RS54753B9 (xx)
RU (1) RU2550812C2 (xx)
SA (1) SA112330134B1 (xx)
SG (1) SG191733A1 (xx)
SI (1) SI2661422T1 (xx)
TN (1) TN2013000274A1 (xx)
TW (1) TWI438180B (xx)
UA (1) UA104122C2 (xx)
UY (1) UY33845A (xx)
WO (1) WO2012113999A1 (xx)
ZA (1) ZA201305027B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058879B (zh) * 2012-12-20 2015-09-09 安徽悦康凯悦制药有限公司 阿戈美拉汀的制备方法
CN103804232B (zh) * 2014-01-26 2015-08-19 江西同和药业股份有限公司 一种1-氰基-1-(7-甲氧基-3,4-二氢-1-萘基)甲醇酯类化合物及其制备方法和应用
CN107353229B (zh) * 2017-08-08 2019-04-30 许昌恒生制药有限公司 一种阿戈美拉汀中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2866334B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
CN101486665B (zh) 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法

Also Published As

Publication number Publication date
UA104122C2 (uk) 2013-12-25
CN103313965A (zh) 2013-09-18
RU2013136344A (ru) 2015-02-10
NI201300062A (es) 2013-12-11
NZ612173A (en) 2015-08-28
FR2970000B1 (fr) 2013-01-04
US20130289307A1 (en) 2013-10-31
CO6731101A2 (es) 2013-08-15
ES2583682T3 (es) 2016-09-21
US8853449B2 (en) 2014-10-07
AU2012220474B2 (en) 2015-08-20
BR112013017307A2 (pt) 2016-10-04
GEP20156365B (en) 2015-09-10
SI2661422T1 (sl) 2016-08-31
CA2823587C (fr) 2015-11-24
ES2583682T9 (es) 2016-10-31
WO2012113999A8 (fr) 2013-08-01
USRE46218E1 (en) 2016-11-29
CA2823587A1 (fr) 2012-08-30
AU2012220474A1 (en) 2013-07-11
CN103313965B (zh) 2015-08-05
MY162977A (en) 2017-07-31
JO3200B1 (ar) 2018-03-08
EA022077B1 (ru) 2015-10-30
CU24289B1 (es) 2017-12-08
ME02408B (me) 2016-09-20
AP3609A (en) 2016-02-26
CR20130301A (es) 2013-08-08
EA201300794A1 (ru) 2014-02-28
EP2661422B9 (fr) 2016-09-07
IL227281A0 (en) 2013-09-30
AR084780A1 (es) 2013-06-26
DK2661422T3 (en) 2016-10-24
ZA201305027B (en) 2014-03-26
AP2013007022A0 (en) 2013-07-31
CU20130092A7 (es) 2013-08-29
SG191733A1 (en) 2013-08-30
JP2014509309A (ja) 2014-04-17
RS54753B1 (sr) 2016-10-31
EP2661422B1 (fr) 2016-04-20
EP2661422A1 (fr) 2013-11-13
PL2661422T3 (pl) 2016-10-31
PE20140037A1 (es) 2014-02-01
JP5837616B2 (ja) 2015-12-24
IL227281A (en) 2015-06-30
HUE028471T2 (en) 2016-12-28
CL2013001882A1 (es) 2013-12-06
ECSP13012735A (es) 2013-09-30
TN2013000274A1 (fr) 2014-11-10
TWI438180B (zh) 2014-05-21
UY33845A (es) 2012-07-31
SA112330134B1 (ar) 2014-08-25
MX2013007837A (es) 2013-09-06
TW201309623A (zh) 2013-03-01
RU2550812C2 (ru) 2015-05-20
HRP20160713T1 (hr) 2016-07-29
KR20130115345A (ko) 2013-10-21
CY1117774T1 (el) 2017-05-17
RS54753B9 (sr) 2019-09-30
KR101543432B1 (ko) 2015-08-10
WO2012113999A1 (fr) 2012-08-30
FR2970000A1 (fr) 2012-07-06

Similar Documents

Publication Publication Date Title
EP2744336A4 (en) METHOD AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF MACROLACTAMEN
IL246265B (en) A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds
HRP20160692T1 (hr) Postupak za proizvodnju intermedijera estetrola
PL2531286T3 (pl) Sposób syntezy metanolu
EP2550269A4 (en) PROCESS AND INTERMEDIATES FOR THE PREPARATION OF LAPATINIB
EP2771006A4 (en) PROCESS FOR THE PREPARATION OF BETA-3-AGONISTS AND INTERMEDIATE PRODUCTS
IL220936A0 (en) Process for the synthesis of lacosamide
ZA201308445B (en) Process for the production of estetrol intermediates
PL2627656T3 (pl) Sposób wytwarzania dihydropterydynonów i ich produktów pośrednich
IL232735A (en) Process for the purification of polyaminocarboxylates
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
IL223066A (en) A process for taptadol synthesis and its intermediates
PL2444390T3 (pl) Sposób wytwarzania Lakozamidu
EP2681188A4 (en) amidation
HK1189571A1 (en) Process and intermediates for synthesizing agomelatine
EP2909166A4 (en) PROCESS FOR THE PREPARATION OF AGOMALATIN USING NEW INTERMEDIATES
SI2739610T1 (sl) Postopek za izdelavo ivabradina in intermediatov za sintezo le-tega
HK1189217A1 (en) Process for synthesizing agomelatine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230104